After having considered the elements which can rightly address to a precox diagnosis of the multiple myeloma, the AA. analyse the principal laboratory exams. Then, they refer about different therapeutic certificates underlining that the obtained results by the Prof. Reizenstein and Mathè teams are nearly corresponding. They discuss about the compositions and posologies of the most present therapeutic certificates underlining the importance of a precox diagnosis.

Therapeutic choices in myeloma

RAPISARDA, Ernesto;
1988-01-01

Abstract

After having considered the elements which can rightly address to a precox diagnosis of the multiple myeloma, the AA. analyse the principal laboratory exams. Then, they refer about different therapeutic certificates underlining that the obtained results by the Prof. Reizenstein and Mathè teams are nearly corresponding. They discuss about the compositions and posologies of the most present therapeutic certificates underlining the importance of a precox diagnosis.
1988
myeloma; drug combination; cancer staging
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/11189
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact